Cutaneous T-cell Lymphoma
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| EMA (1) | CD30 + | Cutaneous T-cell Lymphoma | Brentuximab vedotin |
Precision oncology relationships for therapeutic response involving this cancer type.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| EMA (1) | CD30 + | Cutaneous T-cell Lymphoma | Brentuximab vedotin |